ARCHIVES

Conferees Set NIH Funding At $30 Billion.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

Ivax Paclitaxel To Remain On Market In Deal With BMS.

February 1, 2002

In Brief: “…In Case Mrs. Lasker Happens To See A Senator”; White Potter Defend Center Progress

June 16, 1978

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

In Brief: Wittes To Return To NCI As Chief Of Medicine Branch; Owens Heads Cancer Research Coalition

June 8, 1990

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

Cancer PAC Advocated At AACR Meeting

May 23, 1986